Promise of Low Dose Naltrexone Therapy

Discover the transformative potential of low dose naltrexone therapy in "Promise of Low Dose Naltrexone Therapy" by Elaine A. Moore. Published by McFarland & Co Inc in 2008, this insightful paperback explores the fascinating history of naltrexone, an opiate antagonist initially developed in the 1970s and FDA-approved in 1984 for treating opiate and drug abuse. Spanning 223 pages, the book delves into the drug's therapeutic applications, detailing its effects on the immune system and its unique pharmacological properties. Whether you are a healthcare professional, researcher, or simply curious about innovative therapies, this comprehensive guide offers valuable insights into the evolving landscape of naltrexone therapy. Enhance your understanding of this promising treatment option today!